Literature DB >> 7790475

Oxygen as limiting nutrient for growth of Cryptococcus neoformans.

F C Odds1, T De Backer, G Dams, L Vranckx, F Woestenborghs.   

Abstract

In microbroth cultures with RPMI 1640 medium, the growth yield of seven Cryptococcus neoformans isolates was unaffected by augmentation of the normal (0.2%) glucose concentration in the medium to 2%, and the addition of other potential carbon, nitrogen, and vitamin sources to the medium also failed to produce large changes in growth yield. However, macrobroth cultures of C. neoformans in RPMI 1640 that were agitated by rotation in air gave turbidities 6 to 37 times greater than those in identical cultures incubated statically, and similar levels of increase were seen whether the medium contained 0.2 or 2% glucose. Incubation of microplates under an oxygen atmosphere or with agitation by rotation led to an increase of up to twofold in growth turbidity of the yeast. The maximum increase was achieved by incubation with rotation and was dependent on the brand of microplate used. The findings implicate oxygen as a growth-limiting nutrient for C. neoformans. Incubation of microbroth cultures under conditions that enhance oxygen availability for antifungal susceptibility testing purposes may increase the speed of such tests and enhance the determination of MIC endpoints.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790475      PMCID: PMC228083          DOI: 10.1128/jcm.33.4.995-997.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  2 in total

1.  Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

2.  Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts.

Authors:  F C Odds
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

  2 in total
  13 in total

Review 1.  Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence.

Authors:  Jim Kronstad; Sanjay Saikia; Erik David Nielson; Matthias Kretschmer; Wonhee Jung; Guanggan Hu; Jennifer M H Geddes; Emma J Griffiths; Jaehyuk Choi; Brigitte Cadieux; Mélissa Caza; Rodgoun Attarian
Journal:  Eukaryot Cell       Date:  2011-12-02

2.  Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose.

Authors:  J L Rodríguez-Tudela; F Martín-Díez; M Cuenca-Estrella; L Rodero; Y Carpintero; B Gorgojo
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Peculiar clusters of daughter cells observed in Cryptococcus neoformans grown in sealed microtiter plates.

Authors:  V Raclavský; J Pavlícek; R Novotný; Z Moránová; M Ohkusu; J Trtková; K Takeo; S Kawamoto
Journal:  Folia Microbiol (Praha)       Date:  2009-10-14       Impact factor: 2.099

4.  Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test.

Authors:  J L Rodríguez-Tudela; J V Martinez-Suarez
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

Review 5.  Hypoxia and fungal pathogenesis: to air or not to air?

Authors:  Nora Grahl; Kelly M Shepardson; Dawoon Chung; Robert A Cramer
Journal:  Eukaryot Cell       Date:  2012-03-23

6.  Modified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compounds.

Authors:  T Yoshida; K Jono; K Okonogi
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

7.  Persistence, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients.

Authors:  D Sullivan; K Haynes; G Moran; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  Cryptococcus neoformans gene expression during experimental cryptococcal meningitis.

Authors:  B R Steen; S Zuyderduyn; D L Toffaletti; M Marra; S J M Jones; J R Perfect; J Kronstad
Journal:  Eukaryot Cell       Date:  2003-12

9.  Growth strategy of the pathogenic yeast Cryptococcus neoformans submerged culture under different cultivation formats.

Authors:  V Raclavský; V Husicková; Z Moránová; M Ohkusu; O Fischer; J Precek; J Trtková; K Takeo; S Kawamoto
Journal:  Folia Microbiol (Praha)       Date:  2009-10-14       Impact factor: 2.099

10.  Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities.

Authors:  A Serda Kantarcioğlu; Teun Boekhout; G Sybren De Hoog; Bart Theelen; Ayhan Yücel; Tuba R Ekmekci; Bettina C Fries; Reiko Ikeda; Adem Koslu; Kemal Altas
Journal:  Med Mycol       Date:  2007-03       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.